|
| |
Articles
1-100 out of 100 article(s)
| Title |
Author |
Type |
Date |
Words |
| LFB Provides $10 Million of Funding To GTC Biotherapeutics. |
|
|
Nov 2, 2009 |
878 |
| GTC Biotherapeutics Enters Agreements with LFB for Funding of $12.3 Million with an Option for LFB to Fund an Additional $6.4 Million. |
|
|
Jun 18, 2009 |
1355 |
| Northfield Laboratories Announces Filing of Voluntary Petition under Chapter 11 of the Bankruptcy Code. |
|
|
Jun 1, 2009 |
466 |
| VaxInnate Corporation closes $30 million round of financing. |
|
|
May 14, 2009 |
367 |
| Synageva BioPharma Adds Two New Investors and Announces Additional Funding. |
|
|
May 5, 2009 |
588 |
| BioTime Awarded a $4.7 Million Research Grant from the California Institute for Regenerative Medicine. |
|
|
Apr 30, 2009 |
1490 |
| Genta Secures Up to $12 Million in Convertible Debt Financing. |
|
|
Apr 2, 2009 |
864 |
| $50m for product development. |
Chambers, Heather |
Brief article |
Mar 23, 2009 |
104 |
| GTC Closes $15 Million Convertible Debt Financing from LFB. |
|
|
Dec 23, 2008 |
258 |
| GTC Shareholders Approve Proposals for $15 Million Convertible Debt Financing From LFB. |
|
|
Dec 10, 2008 |
767 |
| United States: Roche still seeking loan for Genentech bid. |
|
|
Dec 3, 2008 |
206 |
| GTC Signs Agreement for $15 Million Convertible Debt Financing From LFB. |
|
|
Nov 3, 2008 |
1046 |
| Orchestra Therapeutics declares bankruptcy. |
Chambers, Heathers |
Brief article |
Oct 27, 2008 |
114 |
| United States: CeNeRx BioPharma completes $15 million Series B financing. |
|
|
Oct 18, 2008 |
516 |
| Two Kyle Bryant translational research awards granted. |
|
|
Sep 22, 2008 |
430 |
| Research and Markets: A Company Profile Analysis of Nabi Biopharmaceuticals: Providing a SWOT Analysis, a Profile of the Competition and Financial Data. |
|
Company overview |
Sep 11, 2008 |
208 |
| United States: Novavax expects to land $18M in financing. |
|
|
Aug 1, 2008 |
205 |
| ORTEC delivers Fuel Inventory Optimization to ease Cash Flow Pinch for Petroleum Marketers. |
|
|
Jul 21, 2008 |
527 |
| United States: Targeted Genetics Corporation Recommended for up to $2.4 Million in Funding by Department of Defense. |
|
|
Jul 12, 2008 |
213 |
| United States: Targeted Genetics Corporation Recommended for up to $2.4 Million in Funding by Department of Defense. |
|
|
Jul 11, 2008 |
216 |
| United States : Cerus Secures $10 Million Revolving Credit Facility. |
|
|
Jun 20, 2008 |
163 |
| Helix BioMedix Secures $3 Million Funding Agreement. |
|
|
Feb 25, 2008 |
797 |
| Seattle Genetics gets shot of cash; $4 million from Genentech; Milestone payment for cancer drug. |
|
|
Jan 8, 2008 |
250 |
| National Foundation for Infectious Diseases Receives Grant from CSL Biotherapies to Increase Flu Vaccination Rates among Healthcare Workers. |
|
|
Oct 18, 2007 |
389 |
| AVI BioPharma Receives Major Research and Development Grant From Charley's Fund for Duchenne Muscular Dystrophy. |
|
|
Oct 15, 2007 |
1063 |
| GTC Biotherapeutics Awarded State Training Grant. |
|
|
Jul 17, 2007 |
974 |
| Hercules Provides $3 Million of Venture Debt to NuGEN Technologies, a Biotechnology Company Specializing in Gene Expression Analysis. |
|
|
Apr 19, 2007 |
655 |
| Cerus Corporation Awarded Grants for Its Listeria-Based Vaccine Platforms. |
|
|
Mar 5, 2007 |
738 |
| GTC Biotherapeutics Awarded $1.4 Million in Continued SBIR Funding For CD137 Monoclonal Antibody Program. |
|
|
Oct 5, 2006 |
582 |
| RegeneRx Receives $545,000 Grant from FDA; Funding for Clinical Development of TB4 for Epidermolysis Bullosa. |
|
|
Aug 9, 2006 |
979 |
| NORTHFIELD LABS REPORTS 'O6 FISCAL 3RD QTR NET LOSS OF 6.4 MIL. |
|
|
May 1, 2006 |
608 |
| DOR BioPharma Announces Private Equity Financing of $3.65 Million with Institutional Investors. |
|
|
Apr 6, 2006 |
1160 |
| GTC Biotherapeutics to Raise $16.7 Million in Registered Direct Offering. |
|
|
Dec 8, 2005 |
622 |
| AmeriPath, Inc. Announces Plans to Refinance Its Existing Credit Facilities. |
|
|
Nov 10, 2005 |
539 |
| VIRAGEN RESTRUCTURES DEBT WITH NEW FINANCING AGREEMENTS. |
|
|
Nov 1, 2005 |
576 |
| Finding more funding. |
Weeks, Katie |
|
Sep 12, 2005 |
151 |
| InterveXion Therapeutics LLC, a Little Rock company started in the biomedical business incubator at the University of Arkansas for Medical Sciences in Little Rock, and Medicago, a Canadian biopharmaceutical company, have formed a multiyear product co-development collaboration. |
|
Brief Article |
Jun 13, 2005 |
76 |
| Diversa Corp.'s efforts lead to $300,000 milestone payment. |
Webb, Marion |
Brief Article |
Sep 27, 2004 |
135 |
| Chiron study suggests inhaled cyclosporine significantly increases transplant patient survival. |
|
Brief Article |
May 30, 2004 |
263 |
| Hyalozyme wraps financing round: Hyalozyme Therapeutics Inc. |
Webb, Marion |
Brief Article |
Feb 16, 2004 |
94 |
| NuGEN Technologies received a Phase I Small Business Innovation Research grant. |
|
|
Oct 31, 2003 |
28 |
| HemaCare Corp. |
|
Brief Article |
Sep 29, 2003 |
48 |
| Going public. |
|
|
Sep 1, 2003 |
377 |
| Biotechs likely to reopen the IPO window: several local firms may follow CancerVax's lead. |
Webb, Marion |
|
Aug 25, 2003 |
948 |
| BIOGEN EXPECTS QUARTERLY EARNINGS TO BE UNEVEN DURING 2003. |
|
Brief Article |
Aug 1, 2003 |
278 |
| Idec's quarterly earnings show solid growth: Genetronics raises $15.67 million in stock offerings, wraps restructuring phase. |
Webb, Marion |
|
Jul 28, 2003 |
560 |
| CYANOTECH REPORTS NET SALES UP 18% FOR 4TH QTR 2003. |
|
|
Jul 1, 2003 |
992 |
| Diversa wins defense grant to develop diagnostic antibodies against anthrax. (Biotech). |
Webb, Marion |
Brief Article |
Jun 23, 2003 |
118 |
| Protein Polymer closes funding. (Cyberbucks). |
Allen, Mike |
Brief Article |
Jun 23, 2003 |
90 |
| Proxy: Diversa Corp. |
|
|
Jun 23, 2003 |
468 |
| Tecan. |
|
|
May 31, 2003 |
363 |
| IDEC Pharmaceuticals Corp. (Proxy). |
|
|
May 19, 2003 |
438 |
| MEDAREX REPORTS NET LOSS OF $35 MILLION FOR 4TH QTR 2002. |
|
|
May 1, 2003 |
1059 |
| TUTOGEN REPORTS 1ST QTR FY 2003 REVENUES INCREASED 31%. |
|
|
Apr 1, 2003 |
340 |
| Merrill Lynch analyst increases forecast for Idec. (Biotech). |
Webb, Marion |
Brief Article |
Feb 10, 2003 |
298 |
| BioVentures accelerator plans to launch three more. |
Friedman, Mark |
|
Feb 10, 2003 |
705 |
| Cell Genesys receives $15 million license fee from Transkaryotic Therapies. |
|
|
Jan 1, 2003 |
396 |
| Idec stock recovers slightly after analyst's downgrade: lymphoma drug's near-term growth potential is uncertain. (Biotech). |
Webb, Marion |
|
Dec 2, 2002 |
457 |
| Engineered skin companies faltering: ATS filing is second this month for bio-skin companies. (Biotech). |
Webb, Marion |
|
Oct 21, 2002 |
582 |
| ZILA REPORTS HIGHER NET REVENUES FOR 3RD QTR FISCAL '02. |
|
Brief Article |
Aug 1, 2002 |
1236 |
| ENZO BIOCHEM REPORTS INCREASED NET INCOME FOR FISCAL 3RD QTR. |
|
|
Aug 1, 2002 |
1220 |
| BioStratum. (Triangle). |
|
|
Jul 1, 2002 |
40 |
| TITAN REPORTS INCREASE IN REVENUE FOR FISCAL YEAR. |
|
Brief Article |
May 1, 2002 |
1104 |
| GENENTECH REPORTS 22% INCREASE IN FIRST QTR PRODUCT SALES. |
|
Brief Article |
May 1, 2002 |
101 |
| Idec reports its solid first quarter earnings. (Biotech). |
Webb, Marion |
Brief Article |
Apr 29, 2002 |
130 |
| IMMUNE NETWORK REPORTS 9-MONTH NET LOSS OF NEARLY $9 MILLION. |
|
Brief Article |
Jan 1, 2002 |
412 |
| November Heats Up for Biotech; Bio-Defense Cools. (Biotech). |
Webb, Marion |
Brief Article |
Dec 17, 2001 |
430 |
| CERUS REPORTS THIRD QUARTER NET LOSS OF $12.7 MILLION. |
|
Brief Article |
Dec 1, 2001 |
410 |
| Proxy. |
|
Brief Article |
Nov 5, 2001 |
469 |
| A hard lesson to learn. |
Evan, Marie |
Brief Article |
Nov 1, 2001 |
556 |
| ENZON REPORTS 127% INCREASE IN 4TH QTR REVENUES. |
|
Brief Article |
Oct 1, 2001 |
1043 |
| Diversa Corp. |
|
Brief Article |
Sep 17, 2001 |
499 |
| CERUS REPORTS INCREASED NET LOSS FOR SECOND QTR. |
|
Brief Article |
Sep 1, 2001 |
413 |
| ABGENIX REPORTS NET LOSS OF $14.8 MILLION FOR 2ND QTR. |
|
Brief Article |
Sep 1, 2001 |
436 |
| Collateral's collaborate pays dues. |
Webb, Marion |
Brief Article |
Aug 20, 2001 |
155 |
| GENENTECH REPORTS 33% INCREASE IN PRODUCT SALES FOR 2ND QTR. |
|
Statistical Data Included |
Aug 1, 2001 |
1855 |
| Fast Growth Puts Tech Firms on Deloitte's Local List. |
Graves, Brad |
Brief Article |
Jul 30, 2001 |
460 |
| Acacia Ups Stake In Company That Controls V-Chip. |
IBOLD, HANS |
Brief Article |
Jul 23, 2001 |
529 |
| Cytomedix Inc. |
|
Brief Article |
Jul 16, 2001 |
68 |
| MICROBIX REPORTS 104% RISE IN SALES AND PROFITABILITY. |
|
Brief Article |
Jul 1, 2001 |
425 |
| CORIXA REPORTS STRONG FIRST QUARTER RESULTS. |
|
Statistical Data Included |
Jun 1, 2001 |
1251 |
| Idec Reports Strong First-Quarter Earnings. |
|
Brief Article |
Apr 30, 2001 |
130 |
| ORGANOGENESIS 4TH QUARTER APLIGRAF SALES SURPASS 4000 UNITS. |
|
Brief Article |
Feb 1, 2001 |
223 |
| CERUS REPORTS NET LOSS OF $9.2 MILLION FOR 3RD. QTR. |
|
Brief Article |
Dec 1, 2000 |
537 |
| Venture Capitalists Back Utah Biomedical Companies. |
|
Brief Article |
Nov 1, 2000 |
292 |
| BIOGEN REPORTS 10% INCREASE IN NET INCOME FOR 3RD QTR. |
|
Brief Article |
Nov 1, 2000 |
721 |
| GENENTECH REPORTS 25% INCREASE IN SALES FOR 3RD. QTR. |
|
Brief Article |
Nov 1, 2000 |
1500 |
| KEEPING THE FAITH. |
Parker, Jayson |
|
Sep 1, 2000 |
2928 |
| BIOGEN REPORTS AVONEX SALES UP 30% FOR SAME QTR. 1999. |
|
Brief Article |
Aug 1, 2000 |
447 |
| Idec's Faith in Cancer Drug Bolstered By Stock Surge. |
WEBB, MARION |
Brief Article |
Jul 24, 2000 |
686 |
| INTERLEUKIN GENETICS REPORTS FIRST QTR. NET LOSS. |
|
Brief Article |
Jul 1, 2000 |
201 |
| GENENTECH REPORTS 21% INCREASE IN 1ST QTR PRODUCT SALES. |
|
Brief Article |
May 1, 2000 |
1842 |
| LIFECELL REPORTS 1999 PRODUCT SALES INCREASE 64% OVER 1998. |
|
Brief Article |
Apr 1, 2000 |
755 |
| Alfred Mann's Magic Boosts Company's Cancer Vaccine. |
NETHERBY, JENNIFER |
Brief Article |
Mar 27, 2000 |
858 |
| Kremer. |
|
Brief Article |
Mar 22, 2000 |
176 |
| BIOGEN REPORTS AVONEX 4TH QTR 1999 SALES OF ABOUT $180 MILLION. |
|
Brief Article |
Mar 1, 2000 |
318 |
| Biotech Receives Venture Capital Funding. |
|
Brief Article |
Jan 17, 2000 |
124 |
| Serologicals Reports Record Quarterly Results; Net Income Up 27% for Quarter. |
|
|
Oct 27, 1998 |
818 |
| ATS Medical Announces Strong Quarterly Growth, Australian Approval and 25,000 Implants. |
|
|
Oct 21, 1998 |
693 |
| V.I. Technologies, Inc. Reports Third Quarter and Nine Months Results. |
|
|
Oct 20, 1998 |
894 |
|
